Teglutik Liquid
Product Images NDC 70726-0306

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Teglutik (NDC 70726-0306). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Edw Pharma, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton (Uklabel)

This is a description of a medication called "TEGLUTIK" which is an oral suspension containing riluzole. It comes in a bottle of 300ml with a recommended dosing range.*

FDA Label Image

Label (Ukbottle)

This is a description of Teglutik, a 5mg/ml oral suspension of riluzole. Each bottle contains 300ml of the oral suspension. It is manufactured by TTALFARMACO SA in Spain. The suspension contains liquid sorbitol and should be used within 15 days after opening. It can be administered orally or via feeding tubes. Remember to shake the bottle gently before use and keep it out of reach of children. Be sure to read the package leaflet before use.*

FDA Label Image

Label (Tiglitik Label)

This is a label for a medication named "Tiglutik." It is an oral suspension for administration and comes in a 300ml bottle. Instructions include shaking the bottle gently before use. The text also mentions "For Oral Administration" and provides some details about the product.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.